Table 2 Risk factors for unsuppressed VL among PLHIV
Variables | Level | Logistic regression analysis | |
|---|---|---|---|
Unadjusted | Adjusted | ||
OR (95% CI) | aOR (95% CI) | ||
Age group (years) | 15–24 | 1 | 1 |
25–34 | 0.39 (0.09, 1.67) | 0.52 (0.10, 2.73) | |
35 and more | 1.57 (0.33, 7.48) | 2.32 (0.35, 15.18) | |
Sex | Female | 1 | 1 |
Male | 1.36 (0.36, 5.13) | 1.41 (0.28, 7.09) | |
Baseline CD4 (cells/ml) | 500 and more | 1 | 1 |
Less than 500 | 1.25 (0.26, 6.03) | 1.65 (0.27, 10.10) | |
VL before IAC (copies/ml) | Less or equal to 10,000 | 1 | 1 |
More than 10,000 | 0.52 (0.15, 1.78) | 0.51 (0.12, 2.23 | |
Baseline WHO clinical stage | Stage I and II | 1 | 1 |
Stage III and IV | 2.07 (0.12, 35.36) | 1.19 (0.04, 38.82) | |
Increasing the frequency of IAC sessions | 1-unit increase | 4.53* (1.39, 14.74) | 5.09* (1.35, 19.10) |